355 related articles for article (PubMed ID: 23975266)
21. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
[TBL] [Abstract][Full Text] [Related]
22. Environmental factors and genetic susceptibility promote urinary bladder cancer.
Volanis D; Kadiyska T; Galanis A; Delakas D; Logotheti S; Zoumpourlis V
Toxicol Lett; 2010 Mar; 193(2):131-7. PubMed ID: 20051252
[TBL] [Abstract][Full Text] [Related]
23. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
Chung W; Bondaruk J; Jelinek J; Lotan Y; Liang S; Czerniak B; Issa JP
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1483-91. PubMed ID: 21586619
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation in bladder cancer: biological pathways and translational applications.
Sánchez-Carbayo M
Tumour Biol; 2012 Apr; 33(2):347-61. PubMed ID: 22274923
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
[TBL] [Abstract][Full Text] [Related]
27. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
Gonzalgo ML; Datar RH; Schoenberg MP; Cote RJ
Urol Oncol; 2007; 25(3):228-35. PubMed ID: 17483020
[TBL] [Abstract][Full Text] [Related]
28. [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
Mikhailenko DS; Nemtsova MV
Urologiia; 2016 Feb; (1):100-105. PubMed ID: 28247712
[TBL] [Abstract][Full Text] [Related]
29. [THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].
Mikhailenko DS; Kushlinskii NE
Klin Lab Diagn; 2016 Feb; 61(2):78-83. PubMed ID: 27455559
[TBL] [Abstract][Full Text] [Related]
30. Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNA.
Ghanjati F; Beermann A; Hermanns T; Poyet C; Araúzo-Bravo MJ; Seifert HH; Schmidtpeter M; Goering W; Sorg R; Wernet P; Santourlidis S
Cancer Biomark; 2014; 14(5):295-302. PubMed ID: 25171471
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
33. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
34. RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
Yoon HY; Kim YJ; Kim JS; Kim YW; Kang HW; Kim WT; Yun SJ; Ryu KH; Lee SC; Kim WJ
Oncol Rep; 2016 Feb; 35(2):1195-203. PubMed ID: 26575865
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation-based biomarkers in bladder cancer.
Kandimalla R; van Tilborg AA; Zwarthoff EC
Nat Rev Urol; 2013 Jun; 10(6):327-35. PubMed ID: 23628807
[TBL] [Abstract][Full Text] [Related]
36. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
37. [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
Gaisa NT
Pathologe; 2016 Nov; 37(Suppl 2):196-203. PubMed ID: 27613302
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
39. Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.
Oliveira AI; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2012 Nov; 12(8):871-8. PubMed ID: 23249204
[TBL] [Abstract][Full Text] [Related]
40. Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.
Köhler CU; Bryk O; Meier S; Lang K; Rozynek P; Brüning T; Käfferlein HU
Biochem Biophys Res Commun; 2013 Aug; 438(1):48-53. PubMed ID: 23867826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
